These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 17210219

  • 1. Screening history of women in Malmö with invasive cervical cancer.
    Lindqvist PG, Hellsten C, Rippe A.
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
    [Abstract] [Full Text] [Related]

  • 2. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 3. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P, Sadler L, Peters J, Crengle S, Bethwaite P, Medley G, Jackson R.
    BJOG; 2007 Apr 07; 114(4):398-407. PubMed ID: 17166215
    [Abstract] [Full Text] [Related]

  • 4. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M, Daltveit AK, Thoresen SO, Nygård JF.
    BMC Health Serv Res; 2007 Jan 23; 7():10. PubMed ID: 17244348
    [Abstract] [Full Text] [Related]

  • 5. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L.
    J Med Screen; 2005 Jan 23; 12(1):7-11. PubMed ID: 15814014
    [Abstract] [Full Text] [Related]

  • 6. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF, Werner B, Totsugui J, Collaço LM, Araújo SR, Huçulak M, Boza EJ, Fischer RM, De Laat L, Sobbania LC, Raggio A.
    Diagn Cytopathol; 2003 Jul 23; 29(1):49-54. PubMed ID: 12827718
    [Abstract] [Full Text] [Related]

  • 7. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
    Jensen H, Svanholm H, Støvring H, Bro F.
    J Epidemiol Community Health; 2009 Jul 23; 63(7):510-5. PubMed ID: 19228681
    [Abstract] [Full Text] [Related]

  • 8. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ, Keane DP, Flannelly GM, Lenehan PM, Murphy JF, Foley ME.
    Ir Med J; 1990 Jun 23; 83(2):61-2. PubMed ID: 2202697
    [Abstract] [Full Text] [Related]

  • 9. The agreement between self-reported cervical smear abnormalities and screening programme records.
    Canfell K, Beral V, Green J, Cameron R, Baker K, Brown A.
    J Med Screen; 2006 Jun 23; 13(2):72-5. PubMed ID: 16792828
    [Abstract] [Full Text] [Related]

  • 10. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC, Fendrick AM, Ellis J, Bernstein SJ.
    J Am Coll Radiol; 2004 Oct 23; 1(10):769-76. PubMed ID: 17411698
    [Abstract] [Full Text] [Related]

  • 11. How do women who choose not to participate in population-based cervical cancer screening reason about their decision?
    Blomberg K, Ternestedt BM, Törnberg S, Tishelman C.
    Psychooncology; 2008 Jun 23; 17(6):561-9. PubMed ID: 17886262
    [Abstract] [Full Text] [Related]

  • 12. Hispanic acculturation and utilization of cervical cancer screening in the US.
    Shah M, Zhu K, Wu H, Potter J.
    Prev Med; 2006 Feb 23; 42(2):146-9. PubMed ID: 16297444
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical impact of quality assurance in an organized cervical screening program.
    Andrae B, Smith P.
    Acta Obstet Gynecol Scand; 1999 May 23; 78(5):429-35. PubMed ID: 10326890
    [Abstract] [Full Text] [Related]

  • 15. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S, Morrell S, Zuo Y, Baker D.
    J Med Screen; 2008 May 23; 15(1):36-43. PubMed ID: 18416954
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M, Hoque E, Kader SB.
    East Afr J Public Health; 2008 Aug 23; 5(2):111-6. PubMed ID: 19024420
    [Abstract] [Full Text] [Related]

  • 17. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA, Schutter EM, Looijen-Salamon M, Martens JE, Siesling S.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug 23; 139(2):204-9. PubMed ID: 18093720
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of the follow-up of women aged 50-74 years after cervical cytological Ascus abnormalities in cancer screening: adherence to clinical practice guidelines in Isere, France; 1991-2000].
    Billette-de-Villemeur A, Poncet F, Garnier A, Marron J, Le Marc'hadour F, Morens A, Rouault-Plantaz V, Ney M, Exbrayat C.
    Gynecol Obstet Fertil; 2009 Oct 23; 37(10):787-95. PubMed ID: 19782628
    [Abstract] [Full Text] [Related]

  • 19. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H, Yeh LC, Almendral B, Neal H.
    N Z Med J; 2009 Oct 30; 122(1305):15-25. PubMed ID: 19966874
    [Abstract] [Full Text] [Related]

  • 20. [Screening profile of women who have died from cervical cancer].
    Ejersbo D.
    Ugeskr Laeger; 2008 Feb 25; 170(9):727-30. PubMed ID: 18307959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.